 Thomas Bak
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 22 | 2022 | 707 | 1.030 |
Why?
| | Living Donors | 8 | 2022 | 270 | 0.370 |
Why?
| | Hepatic Artery | 3 | 2004 | 49 | 0.310 |
Why?
| | Carcinoma, Hepatocellular | 5 | 2007 | 211 | 0.280 |
Why?
| | Intestinal Fistula | 1 | 2004 | 11 | 0.240 |
Why?
| | Vascular Fistula | 1 | 2004 | 14 | 0.240 |
Why?
| | Duodenal Diseases | 1 | 2004 | 9 | 0.240 |
Why?
| | Liver Neoplasms | 5 | 2007 | 506 | 0.240 |
Why?
| | Aneurysm, False | 1 | 2004 | 45 | 0.230 |
Why?
| | Immunosuppressive Agents | 8 | 2008 | 646 | 0.220 |
Why?
| | Cholangitis, Sclerosing | 4 | 2008 | 66 | 0.170 |
Why?
| | Sirolimus | 3 | 2007 | 181 | 0.130 |
Why?
| | Liver Failure | 2 | 2008 | 75 | 0.130 |
Why?
| | Donor Selection | 1 | 2016 | 66 | 0.130 |
Why?
| | Airway Extubation | 1 | 2016 | 43 | 0.130 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2016 | 129 | 0.120 |
Why?
| | Tissue Donors | 1 | 2016 | 316 | 0.110 |
Why?
| | Cholestasis | 1 | 2016 | 225 | 0.110 |
Why?
| | Graft Rejection | 3 | 2007 | 513 | 0.100 |
Why?
| | Tacrolimus | 3 | 2007 | 134 | 0.090 |
Why?
| | Hypoxia | 1 | 2016 | 958 | 0.080 |
Why?
| | Graft Survival | 5 | 2016 | 446 | 0.080 |
Why?
| | Hepatitis, Autoimmune | 1 | 2008 | 27 | 0.080 |
Why?
| | Hepatic Veins | 1 | 2008 | 29 | 0.070 |
Why?
| | Chemoembolization, Therapeutic | 2 | 2007 | 45 | 0.070 |
Why?
| | Cadaver | 3 | 2004 | 299 | 0.070 |
Why?
| | Hepatectomy | 1 | 2008 | 119 | 0.070 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2006 | 36 | 0.070 |
Why?
| | Tissue and Organ Procurement | 3 | 2004 | 228 | 0.060 |
Why?
| | Portal Vein | 1 | 2006 | 76 | 0.060 |
Why?
| | Disease Transmission, Infectious | 1 | 2006 | 55 | 0.060 |
Why?
| | Bile Ducts | 2 | 2022 | 68 | 0.060 |
Why?
| | Anastomosis, Roux-en-Y | 2 | 2022 | 25 | 0.060 |
Why?
| | Herpes Simplex | 1 | 2006 | 87 | 0.060 |
Why?
| | Middle Aged | 15 | 2016 | 26735 | 0.060 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 497 | 0.060 |
Why?
| | Venous Thrombosis | 1 | 2006 | 140 | 0.060 |
Why?
| | Vena Cava, Inferior | 1 | 2004 | 56 | 0.060 |
Why?
| | Reoperation | 3 | 2016 | 514 | 0.060 |
Why?
| | Survival Analysis | 4 | 2008 | 1211 | 0.050 |
Why?
| | Choledochostomy | 1 | 2022 | 11 | 0.050 |
Why?
| | Treatment Outcome | 7 | 2016 | 9088 | 0.050 |
Why?
| | Hepatocytes | 1 | 2003 | 195 | 0.050 |
Why?
| | Adult | 11 | 2016 | 30546 | 0.050 |
Why?
| | Hospital Costs | 1 | 2003 | 104 | 0.050 |
Why?
| | Humans | 23 | 2022 | 114674 | 0.050 |
Why?
| | Female | 16 | 2016 | 59499 | 0.050 |
Why?
| | Vascular Surgical Procedures | 1 | 2004 | 259 | 0.050 |
Why?
| | Hepatitis C | 1 | 2003 | 219 | 0.050 |
Why?
| | Retrospective Studies | 8 | 2016 | 12549 | 0.050 |
Why?
| | Pancreas Transplantation | 1 | 2000 | 61 | 0.040 |
Why?
| | Male | 16 | 2016 | 55589 | 0.040 |
Why?
| | Recurrence | 3 | 2008 | 935 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2003 | 532 | 0.040 |
Why?
| | Disease-Free Survival | 2 | 2008 | 620 | 0.030 |
Why?
| | Time Factors | 3 | 2016 | 6115 | 0.030 |
Why?
| | Risk Factors | 4 | 2016 | 8632 | 0.030 |
Why?
| | Shock | 1 | 2016 | 84 | 0.030 |
Why?
| | Follow-Up Studies | 3 | 2008 | 4411 | 0.030 |
Why?
| | Erythrocyte Transfusion | 1 | 2016 | 189 | 0.030 |
Why?
| | Cause of Death | 1 | 2016 | 361 | 0.030 |
Why?
| | Health Care Rationing | 2 | 2004 | 45 | 0.030 |
Why?
| | Hemoglobins | 1 | 2016 | 315 | 0.030 |
Why?
| | Cyclosporine | 2 | 2003 | 161 | 0.030 |
Why?
| | Neoplasm Staging | 2 | 2007 | 1167 | 0.020 |
Why?
| | Cohort Studies | 3 | 2008 | 4895 | 0.020 |
Why?
| | Patient Selection | 2 | 2004 | 641 | 0.020 |
Why?
| | Liver | 2 | 2007 | 1637 | 0.020 |
Why?
| | Adolescent | 3 | 2016 | 17841 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 62 | 0.020 |
Why?
| | Functional Laterality | 1 | 2008 | 198 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 2 | 2006 | 2285 | 0.020 |
Why?
| | Portography | 1 | 2006 | 11 | 0.020 |
Why?
| | Delayed-Action Preparations | 1 | 2007 | 159 | 0.020 |
Why?
| | Ultrasonics | 1 | 2006 | 46 | 0.020 |
Why?
| | Colorado | 2 | 2008 | 4099 | 0.020 |
Why?
| | Simplexvirus | 1 | 2006 | 80 | 0.020 |
Why?
| | Biomarkers | 1 | 2016 | 3408 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2007 | 442 | 0.020 |
Why?
| | Blood Vessels | 1 | 2007 | 180 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2008 | 811 | 0.020 |
Why?
| | Aged | 3 | 2008 | 19073 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2006 | 151 | 0.020 |
Why?
| | Treatment Failure | 1 | 2006 | 331 | 0.020 |
Why?
| | Safety | 1 | 2007 | 297 | 0.020 |
Why?
| | Preoperative Care | 1 | 2007 | 319 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2008 | 1075 | 0.010 |
Why?
| | Waiting Lists | 1 | 2006 | 211 | 0.010 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2000 | 3252 | 0.010 |
Why?
| | Survival | 1 | 2004 | 37 | 0.010 |
Why?
| | alpha-Fetoproteins | 1 | 2004 | 31 | 0.010 |
Why?
| | Transplants | 1 | 2004 | 36 | 0.010 |
Why?
| | Microsomes, Liver | 1 | 2003 | 55 | 0.010 |
Why?
| | Outpatients | 1 | 2006 | 326 | 0.010 |
Why?
| | Muromonab-CD3 | 1 | 2003 | 20 | 0.010 |
Why?
| | Cost Control | 1 | 2003 | 39 | 0.010 |
Why?
| | Postoperative Complications | 2 | 2004 | 2128 | 0.010 |
Why?
| | Ultrasonography | 1 | 2006 | 634 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2003 | 143 | 0.010 |
Why?
| | Cost Savings | 1 | 2003 | 74 | 0.010 |
Why?
| | Hospitals, University | 1 | 2003 | 172 | 0.010 |
Why?
| | Child | 2 | 2016 | 18412 | 0.010 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2007 | 858 | 0.010 |
Why?
| | Aspartate Aminotransferases | 1 | 2002 | 86 | 0.010 |
Why?
| | Alanine Transaminase | 1 | 2002 | 141 | 0.010 |
Why?
| | Incidence | 1 | 2007 | 2313 | 0.010 |
Why?
| | Young Adult | 1 | 2016 | 10466 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2003 | 1430 | 0.010 |
Why?
| | Risk Assessment | 1 | 2008 | 2968 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 1796 | 0.010 |
Why?
| | Anastomosis, Surgical | 1 | 1998 | 136 | 0.010 |
Why?
| | Liver Failure, Acute | 1 | 1998 | 58 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2002 | 1842 | 0.010 |
Why?
| | Age Factors | 1 | 2004 | 2894 | 0.010 |
Why?
| | Prevalence | 1 | 2003 | 2251 | 0.010 |
Why?
| | Models, Biological | 1 | 2003 | 1620 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2003 | 2539 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3046 | 0.010 |
Why?
| | Diabetes Mellitus | 1 | 2003 | 900 | 0.010 |
Why?
| | Obesity | 1 | 2003 | 2508 | 0.010 |
Why?
| | Child, Preschool | 1 | 2004 | 9114 | 0.010 |
Why?
|
|
Bak's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|